Ultromics, a health-tech company which applies AI to echocardiography, to earlier detect and better diagnose heart disease, has entered a know-how and clinical research agreement with Mayo Clinic. Underpinned by a determination to drive higher standards of patient care, the collaboration will leverage Mayos cardiology expertise and insights and feed real world data into Ultromics first product to market, EchoGo Core. Continue reading →

President Donald Trump made headlines Monday when he voluntarily told reporters that he was taking hydroxychloroquine, which Trump has frequently touted as a game changer for coronavirus. This announcement was the latest development in Trumps weeks-long campaign in support of the drug, despite several reports and studies that have questioned its effectiveness in treating coronavirus patients. Hydroxychloroquine is an anti-malarial drug often used to treat autoimmune diseases like lupus Continue reading →

QUEBEC CITY, May 20, 2020 /CNW Telbec/ -OpSens Inc. ("OpSens"or the "Company") (TSX: OPS)(OTCQX: OPSSF)reached an important milestone with more than 100,000 patients evaluated with the OptoWire, a pressure guidewire for the diagnosis and treatment of coronary artery stenosis. Accuracy in assessing the severity of coronary disease is critical and pressure guidewires have been shown to improve clinical outcomes when used to diagnose coronary disease Continue reading →